BSE filing, NSE: GUJTERC. Summary written from the filing by ALFA Finder's alert engine.
Gujarat Terce Laboratories Ltd: key numbers
- Share price
- ₹41.78
- Market cap
- ₹31.00 Cr
- Revenue (annual)
- ₹47.47 Cr
- Net profit (annual)
- ₹2.20 Cr
- P/E (TTM)
- 14.8×Sector 46.1×
- Promoter holding
- 40.03%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gujarat Terce Laboratories Ltd
All →Gujarat Terce Laboratories Other Announcement
Gujarat Terce Laboratories Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.
Gujarat Terce Laboratories Annual General Meeting
Gujarat Terce Laboratories held its 41st Annual General Meeting on August 21, 2026. Members passed resolutions regarding financial statements and director re-appointments.
Gujarat Terce Laboratories Management Change
Gujarat Terce Laboratories issued a corrigendum clarifying the re-appointment tenure of its MD & CEO, Mr. Aalap Prajapati, as three years instead of five.
Gujarat Terce Laboratories Q1 FY27 Results: Net Loss of ₹0.2 Cr
Gujarat Terce Laboratories Ltd reported revenue from operations of ₹9 Cr (-17.4% YoY) and a net loss of ₹0.2 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.2 Cr
Gujarat Terce Laboratories Board Meeting Date
Gujarat Terce Laboratories will hold a board meeting on 7 August 2026 to approve the unaudited standalone financial results for the quarter ended 30 June 2026.
Gujarat Terce Laboratories Annual Report
Gujarat Terce Laboratories Ltd has filed its Annual Report for the financial year 2025-26 and notice of its 41st Annual General Meeting.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.